- Original Articles GLP-1 RA and Reduced Liver and Non-Liver Complications in Adults with T2D and MASLD: A Target Trial Emulation Study
- Xianhua Mao, Xinrong Zhang, Rongtao Lai, Ka-Shing Cheung, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, Mindie H Nguyen
- DOI: 10.3350/cmh.2024.1096 [Epub ahead of print]
- Editorials Besifovir: a viable option for long-term disease control in chronic hepatitis B
- Wai-Kay Seto
- DOI: 10.3350/cmh.2025.0305 [Epub ahead of print]
- Original Articles Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters
- Lung-Yi Mak, Mark Anderson, Michael Stec, Matthew Shing-Hin Chung, Danny Ka-Ho Wong, Rex Wan-Hin Hui, Wai-Kay Seto, Gavin Cloherty, Man-Fung Yuen
- Clin Mol Hepatol. 2025;31(2):460-473.
- Reviews Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
- Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
- Clin Mol Hepatol. 2025;31(Suppl):S182-S195.
- Prospect of emerging treatments for hepatitis B virus functional cure
- Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2025;31(Suppl):S165-181.
- Letters to the Editor Functional cure of chronic hepatitis B encounters resmetirom
- Nai-Bin Yang, Wai-Kay Seto, Ming-Hua Zheng
- Clin Mol Hepatol. 2024;30(3):580-581.
- Editorial The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
- Xianhua Mao, Lung Yi Mak, Wai-Kay Seto
- Clin Mol Hepatol. 2023;29(3):690-692.
- Reviews Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
- Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(2):217-229.
- Screening strategy for non-alcoholic fatty liver disease
- Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
- Clin Mol Hepatol. 2023;29(Suppl):S103-S122.
- Correspondences Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
- Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(1):191-193.
- Reviews RNA interference as a novel treatment strategy for chronic hepatitis B infection
- Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2022;28(3):408-424.